Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1).
Hideto KamedaKohei HagimoriYoji MorisakiThorsten HolzkämperAyako KonomiHiroaki DobashiPublished in: Rheumatology and therapy (2023)
ClinicalTrials.gov identifier, NCT01695239.